Contract manufacturing revenue — Total Revenue
Biogen Contract manufacturing revenue — Total Revenue increased by 675.2% to $237.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.0%, from $282.30M to $237.20M. Over 4 years (FY 2021 to FY 2025), Contract manufacturing revenue — Total Revenue shows an upward trend with a 12.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests higher utilization of manufacturing facilities and stronger demand for external production services, while a decrease may indicate reduced capacity or contract expirations.
Detailed definition
This metric represents the total gross revenue generated from providing contract manufacturing services to third-party p...
Peer comparison
Commonly reported by large-cap biopharma companies with significant internal manufacturing infrastructure and CDMO capabilities.
biib_segment_contract_manufacturing_revenue_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.93M | $106.93M | $106.93M | $47.50M | $81.20M | $114.20M | $174.80M | $306.90M | $183.10M | $252.90M | $105.30M | $152.20M | $100.00M | $221.90M | $118.00M | $282.30M | $225.00M | $141.50M | $30.60M | $237.20M |
| QoQ Change | — | +0.0% | +0.0% | -55.6% | +70.9% | +40.6% | +53.1% | +75.6% | -40.3% | +38.1% | -58.4% | +44.5% | -34.3% | +121.9% | -46.8% | +139.2% | -20.3% | -37.1% | -78.4% | +675.2% |
| YoY Change | — | — | — | — | -24.1% | +6.8% | +63.5% | +546.1% | +125.5% | +121.5% | -39.8% | -50.4% | -45.4% | -12.3% | +12.1% | +85.5% | +125.0% | -36.2% | -74.1% | -16.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's contract manufacturing revenue — total revenue?
- Biogen (BIIB) reported contract manufacturing revenue — total revenue of $237.20M in Q1 2026.
- How has Biogen's contract manufacturing revenue — total revenue changed year-over-year?
- Biogen's contract manufacturing revenue — total revenue decreased by 16.0% year-over-year, from $282.30M to $237.20M.
- What is the long-term trend for Biogen's contract manufacturing revenue — total revenue?
- Over 4 years (2021 to 2025), Biogen's contract manufacturing revenue — total revenue has grown at a 12.3% compound annual growth rate (CAGR), from $427.70M to $679.40M.
- What does contract manufacturing revenue — total revenue mean?
- Total income earned from manufacturing pharmaceutical products for other companies.